How does a company with zero revenue and a vacant Chief Medical Officer hit a $30 billion valuation? It doesn’t—not legally. This is the story of Regencell Bioscience, a scheme so blatant it triggered a DOJ criminal probe. Today, we’re dissecting exactly how they built this house of cards, and how it all came crashing […]

Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation

A podcast that dives headfirst into the fog of information. Go beyond the headlines to explore the glitches in the system, the anomalies in the data, and the questions that the mainstream media is too afraid to ask. Each episode is a deep dive into the forces that are shaping our world, from the weaponization of technology to the erosion of our financial sovereignty. This is the podcast for listeners who aren't afraid to look behind the curtain.

Share Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation

Sign up to save your podcasts

Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation

Zero Revenue, 46,000% Surge: The Absurd Anatomy of the Regencell Bioscience Stock Fraud Investigation